|
Project Title
|
Midazolam Medroxyprogesteron as Raw Material
for Drug, and Its Intermediate
|
Cooperation
Form
|
Joint Venture or Cooperation
|
|
|
ProjectScheme,
Construction
Planning,
Marketing Analysis,
Business Scaleand
Estimated Sales
|
The
scale of production: an annual output of 200T midazolam medroxyprogesteron
as raw material for drug, and its intermediate. Midazolam medroxyprogesteron
is a chemical synthetic drug. It is in short supply because
of the wide application, the high potential in deep processing
and a brisk market. Our products would be exported for 80 percent
of the total to Europe, the Middle East and other countries
and regions.
It is predicted that the annual sales income would be
300 million yuan with the annual profit of 52 million yuan. |
Equipment Tobe Importedand Rawmaterials to Be Supplied
|
Intended
to import the test instruments. |
Estimated Investment and Benefit Analysis
|
Total
Investment
|
USD
5 million
|
Registered
Capital
|
USD
3 million
|
Annual
Salesincome
|
RMB
300 million
|
|
Investment Form of Foreign Partner
|
Annual
profit
|
RMB
52 million
|
|
Cash
|
Technology
|
Equipment
|
Brand
|
Others
|
Internal
Rateof
Recovery
|
50 percent
|
|
¡Ì
|
-
|
-
|
-
|
-
|
Recovery
Periodof
Investment
|
1.25 years
|
Present Status of Chinese Partner(Current Ownership, Total
Assets and Fixedassets, Present Products and Sales, Present
Equipment Andtechnology and Facilities, etc.)
|
Ningbo Renjian
Pharmaceuticals Co., Ltd., a high-tech enterprise, is specialized
in producing medicine and chemical reagent. With the total assets
of 45.98 million yuan, it employs over 200 workers and staff
members, including more than 40 engineers and technicians. Skilled
hands and advanced equipment have enabled the company to be
the largest productive base for human chorionic genadotrophin
in China. The company-made chemical synthetic drug, biochemical
pharmaceuticals, and medicine for animals have been exported
for over 90 percent of the total to Europe, America, Southeast
Asian Countries and other countries and regions, making 28 million
yuan in the sales income in 2000. |
|
Location Advantage
|
The
project will be located at the planned Ningbo Chemicals Zone,
only 16Km from the largest liquified chemicals dock in China,
connected with No.329 national highway. It has a convenient
transport service. Water, power and gas are available. The zone
can enjoy the same preferential treatments as that of the Ningbo
city-levelled ETD Zone. |
|
Process of The Project
|
The factory
building for the project is now under preparation. |
Document
Savailable
|
Documents
for foreign investment are available. |
|
Chinese Partner to Contact
|
Ningbo
Renjian Pharmaceuticals Co.,Ltd. |
Person to
Contact
|
Cen Jian |
|
Address
|
Yuantong
village, Zonghan Town, Cixi City,Zhejiang,China |
Post Code
|
315301 |
|
Telephone
|
0086
- 574 - 63013113 |
Fax
|
0086
- 574 - 63011512 |
|
E-mail
|
- |
Website
|
- |
Municipal Liaison Department: Ningbo Municipal Commission
of Foreign Trade and Economic Cooperation
(Ningbo foreign Investment Development Board)
Address: 190 Lingqiao Road, Ningbo 315000, P.R.China
Telephone: 86-574-87327023(Information Liaison Dept.), 87315735(The
First Sector Dept.), 87310671(The Second Sector Dept.)
Fax:86-574-87315992, 87327429
E-mail: xmb@ningbochina.com
Website: www.ningbochina.com
|
THE PROPOSED PROJECTS
FOR INTERNATIONAL ECONOMIC